Variant position: 351 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 616 The length of the canonical sequence.
Location on the sequence:
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human KITVRSNNREVAKRNIYLMD TSGKVVTATLWGEDADK--FDGS
Mouse KITVKSNNREVAKRNIYLMD MSGKVVTTTLWGEDADK--FD
Chicken KIVVKASNREVSKRNVHLMD TSGKLVTATLWGNEAEK--FD
Xenopus laevis KVTIKSNNREVSKRSIHLMD SSGKVVSTTLWGEDADK--FD
Xenopus tropicalis KVTIRSNNREVSKRNINLMD SSGKVVSTTLWGEDADK--FD
Zebrafish RIMTK-NSREVSKRNIQLID MSGRVIQLTMWGSDAET--FD
Caenorhabditis elegans TEFTSKAGKSLIKREMELID ESGALVRLTLWGDEATKALVD
Drosophila SFVARTTNKEFKKRDITLVD MSNSAISLTLWGDDAVN--FD
Baker's yeast ELTSR-AGKKFDRRDITIVD DSGFSISVGLWNQQALD--FN
Fission yeast QITSRATSRGFDKRDITIVD QTGYEMRVTLWGKTAIE--FS
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
1 – 616 Replication protein A 70 kDa DNA-binding subunit
2 – 616 Replication protein A 70 kDa DNA-binding subunit, N-terminally processed
331 – 331 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)
Totoki Y.; Toyoda A.; Takeda T.; Sakaki Y.; Tanaka A.; Yokoyama S.; Ohara O.; Nagase T.; Kikuno R.F.;
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]; VARIANT ALA-351;
NIEHS SNPs program;
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]; VARIANT ALA-351;
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.